Folate: Effects on Carcinogenesis and the Potential for Cancer Chemoprevention

ONCOLOGY

Volumn 10, Issue 11, 1996, Pages 1727-1743

  Mason, Joel B ^a   Levesque, Tamara ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

ANIMAL; CELL TRANSFORMATION; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COLORECTAL TUMOR; DRUG EFFECT; FEMALE; FOLIC ACID DEFICIENCY; HUMAN; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; REVIEW; UTERINE CERVIX TUMOR;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CHEMOPREVENTION; CLINICAL TRIALS; COLORECTAL NEOPLASMS; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; HUMANS; UTERINE CERVICAL NEOPLASMS;

EID: 0030277195     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (109)

1. Massey B, Rubin C. The stomach in pernicious anemia: A cytologic study. Am J Med Sci 227:481-492, 1954.
2. Kaplan H, Rigler L: Pernicious anemia and carcinoma of the stomach - autopsy studies concerning their interrelationship. Am J Med Sci 209:339-348, 1945.
3. Mosbech J, Videbaek A: Mortality from and risk of gastric carcinoma among patients with pernicious anemia Br Med J 2:390-394, 1950.
4. Norcross J, Munroe S, Griffin B: Development of gastric carcinoma in pernicious anemia. Ann Intern Med 37:338-343, 1952.
5. Van Niekerk W: Cervical cytologic abnormalities caused by folic acid deficiency. Acta Cytol 10:67-73, 1966.
6. Butterworth C Jr, Hatch K, Gore H, et al: Improvement in cervical dysplasia associated with folic acid therapy in users of oral contraceptives. Am J Clin Nutr 35:73-82, 1982.
7. Heimburger D, Alexander C, Birch R, et al: Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12. JAMA 259:1525-1530, 1988.
8. Butterworth C Jr., Hatch K, Macaluso M, et al: Folate deficiency and cervical dysplasia. JAMA 267:528-533, 1992.
9. Reeves W, Brinton L, Garcia M: Human papillomavirus infection and cervical cancer in Latin America. N Engl J Med 320:1437-1441, 1989.
10. Brock K, Berry G, Mock P, et al: Nutrients in diet and plasma and risk of in situ cervical cancer. J Natl Cancer Inst 80:580-585, 1988.
11. Verreault R, Chu J, Mandelson M, et al: A case-control study of diet and invasive cervical cancer. Int J Cancer 43:1050-1054, 1989.
12. Ziegler R, Brinton L, Mammon R, et al: Diet and risk of invasive cervical cancer among white women in the United States. Am J Epidemiol 132:432-445, 1990.
13. Ziegler R, Jones C, Brinton L, et al: Diet and risk of in situ cervical cancer among white women in the United States. Cancer Causes Control 2:17-29, 1991.
14. Potischman N, Brinton L, Laiming V, et al: A case-control study of serum folate levels and invasive cervical cancer. Cancer Res 51:4785-4789, 1991.
15. Butterworth C Jr., Hatch K, Soong SJ, et al: Oral folic acid supplementation for cervical dysplasia: A clinical intervention trial. Am J Obstet Gynecol 166:803-809, 1992.
16. Childers J, Chu J, Voight L, et al: Chemoprevention of cervical cancer with folic acid: A phase III SWOG intergroup study. Cancer Epidemiol Biomarkers Prevent 4:155-159, 1995.
17. Nasiell K, Roger V, Nasiell M: Behavior of mild cervical dysplasia during long-term follow-up. Obstet Gynecol 67:665-669, 1986.
18. Lashner B, Heidenreich P, Su G, et al: The effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. Gastroenterology 97:255-259, 1989.
19. Greenstein A, Sachar D, Smith H, et al: A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer 48:2742-2745, 1981.
20. Franklin J, Rosenberg I: Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyradine (Azulfidine). Gastroenterology 64:517-525, 1973.
21. Halsted C, Gandhi G, Tamura T. Sulfasalazine inhibits the absorption of folates in ulcerative colitis. N Engl J Med 305:1513-1517, 1981.
22. Selhub J, Dhar G, Rosenberg I: Inhibition of folate enzymes by sulfasalazine. J Clin Invest 61:221-224, 1978.
23. Lashner B: Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis. J Cancer Res Clin Oncol 119:549-554, 1993.
24. Freudenheim J, Graham S, Marshall J, et al: Folate intake and carcinogenesis of the colon and rectum. Int J Epidemiol 20:368-374, 1991.
25. Benito E, Stiggelbout A, Bosch F, et al. Nutritional factors in colorectal cancer risk: A case-control study in Majorca. Int J Cancer 49:161-167, 1991.
26. Benito E, Cabeza E, Moreno V, et al: Diet and colorectal adenomas: A case control study in Majorca. Int J Cancer 55.213-217, 1993.
27. Meyer F, White E: Alcohol and nutrients in relation to colon cancer in middle-aged adults. Am J Epidemiol 138:225-236, 1993.
28. Bird C, Swendseid M, Witte J, et al: Red cell and plasma folate, folate consumption and the risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prevent 4:709-714, 1995.
29. Giovannucci E, Stampfer M, Colditz G, et al: Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst 85:875-884, 1993.
30. Giovannucci E, Rimm E, Ascherio A, et al. Alcohol, low-methionine-low folate diets and the risk of colon cancer in men. J Natl Cancer Inst 87:265-273, 1995.
31. Glynn S, Albanes D, Pietinen P, et al: Colorectal cancer and folate status: A nested case control study among male smokers. Cancer Epidemiol Biomarkers Prevent 5:487-494, 1996.
32. Cravo M, Fidalgo P, Pereira A, et al: DNA methylation as an intermediate biomarker in colorectal cancer: Modulation by folic acid supplementation. Eur J Cancer Prevent 3:473-479, 1994.
33. Paspatis G, Karamanolis D: Folate supplementation and adenomatous colonic polyps Dis Colon Rectum 37:1340-1341, 1994.
34. Goelz S, Vogelstein B, Hamilton S, et al Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 28:187-190, 1985.
35. Feinberg A, Gehrke C, Kuo K, et al: Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res 48:1159-1161, 1988.
36. Feinberg A, Vogelstein B: Hypomethylation of ras oncogenes in primary human cancers. Biochem Biophys Res Comm 111:47-54, 1983.
37. Makos M, Nelkin B, Lerman M, et al Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. Proc Natl Acad Sci USA 89:1929-1933, 1992.
38. Cho K, Vogelstein B. Genetic alterations in the adenoma-carcinoma sequence. Cancer 70 (suppl): 1727-1731, 1992.
39. Hamilton S: Molecular genetics of colorectal cancer. Cancer 70:1216-1221, 1992.
40. Piyathilake C, Hine R, Dasanayake A, et al: Effect of smoking on folate levels in buccal mucosal cells Int J Cancer 52:566-569, 1992.
41. Piyathilake C, Macaluso M, Hine R, et al: Cigarette smoking, intracellular vitamin deficiency, and occurrence of micronuclei in epithelial cells of the buccal mucosa. Cancer Epidemiol Biomarkers Prev 4:751-758, 1995.
42. Chen A, Reidy J, Annest J, et al: Increased chromosome fragility as a consequence of blood folate levels, smoking status and coffee consumption. Environ Mol Mutagen 13:319-324, 1989.
43. Jaskiewicz K, Marasas W, Lazarus C, et al: Association of esophageal cytological abnormalities with vitamin and lipotrope deficiencies in populations at risk for esophageal cancer. Anticancer Res 8:711-716, 1988.
44. Jaskiewicz K: Oesophageal carcinoma: Cytopathology and nutritional aspects in aetiology. Anticancer Res 9:1847-1852, 1989.
45. Mark S, Liu S, Li J, et al: The effect of vitamin and mineral supplementation on esophageal cytology: Results from the Linxian dysplasia trial. Int J Cancer 57:162-166, 1994.
46. LaVecchia C, Ferraroni M, D'Avanzo B, et al: Selected micornutrient intake and the risk of gastric cancer. Cancer Epidemiol Biomarkers Prev 3:393-398, 1994.
47. Cravo M, Mason J, Dayal Y, et al: Folate deficiency enhances the development of colonic neoplasia in dimethylhydrazine-treated rats. Cancer Res 52:5002-5006, 1992.
48. Rogers A, Nauss K: Rodent models of carcinoma of the colon. Digest Dis Sci 308(suppl):7S-102S, 1985.
49. Yander G, Halsey H, Kenna M, Augenlicht L: Amplification and elevated expression of c-myc in a chemically induced mouse colon tumor. Cancer Res 45:4433-4438, 1985.
50. Caignard A, Kitagawa Y, Sato S, et al: Activated k-ras in tumorigenic and non-tumorigenic cell variants from a rat colon adenocarcinoma, induced by dimethylhydrazine. Jpn J Cancer Res 79:244-249, 1988.
51. Walzem R, Clifford A: Folate deficiency in rats fed diets containing free amino acids or intact proteins. J Nutr 118:1089-1096, 1988.
52. Kim YI, Salomon R, Graeme-Cook F, et al: Dietary folate protects against the development of macroscopic colonic neoplasms in a dose-responsive manner in the dimethylhydrazine rat model. Gut 1996 (in press).
53. Wargovitch M, Chen C-D, Jimenez A, et al: Aberrant crypts as a biomarker for colon cancer: Evaluation of potential chemopreventive agents in the rat. Cancer Epidemiol Biomarkers Prevent 5:355-360, 1996.
54. Newberne P, Rogers A: Labile methyl groups and the promotion of cancer. Annu Rev Nutr 6:407-432, 1986.
55. Razin A, Cedar H: DNA methylation and gene expression. Microbiol Rev 55:451-458, 1991.
56. Gardiner-Garden M, Frommer M: CpG islands in vertebrate genomes. J Molec Biol 196:261-282, 1987.
57. Ordonez L, Wurtman R: Folic acid deficiency and methyl group metabolism in rat brain: Effects of L-dopa. Arch Biochem Biophys 160:372-376, 1974.
58. Henning S, McKee R, Sweinseid M: Hepatic content of S-adenosylmethionine, Sadenosylhomocysteine and glutathionine in rats receiving treatments modulating methyl donor availability. J Nutr 119:1478-1482, 1989.
59. Wainfan E, Dizik M, Stender M, et al: Rapid appearance of hypomethylated DNA in livers of rats fed cancer-promoting, methyl-deficient diets. Cancer Res 49:4094-4097, 1989.
60. Ghoshal A, Farber E: The induction of liver cancer by a dietary deficiency of choline and methionine without added carcinogens. Carcinogenesis 5:1367-1370, 1984.
61. Dizik M, Christman J, Wainfan E: Alterations in expression and methylation of specific genes in livers of rats fed a cancer-promoting methyl-deficient diet. Carcinogenesis 12:1307-1312, 1991.
62. Bestor T: Methylation patterns in the vertebrate genome. J Natl Inst Health Res 5:57-60 1993.
63. Meehan R, Lewis J, McKay S, et al: Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell 58.499, 1989.
64. Kim Y-I, Christman J, Fleet J, et al: Moderate folate deficiency does not cause global hypomethylation of hepatic and colonic DNA or c-myc specific hypomethylation of colonic DNA in rats. Am J Clin Nutr 61:1083-1090, 1995.
65. Balaghi M, Wagner C: DNA methylation in folate deficiency: Use of CpG methylase. Biochem Biophys Res Comm 193:1184-1190, 1993.
66. Kim Y-I, Pogribny I, Basnakian A, Miller J, Selhub J, James SJ, Mason JB. Folate deficiency in the rat induces DNA strand breaks and hypomethylation within mutational 'hot spots' of the p53 gene. Am J Clin Nutr 1996 (in press).
67. Kim Y-I, Pogribny I, Salomon R, et al: DNA hypomethylation of the p53 gene of rat colon induced by dimethylhydrazine: Modulation by dietary folate. Am J Pathol 149:1129-1137, 1996.
68. Laird P, Jackson-Grusby L, Fazeli A, et al: Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81:197-205, 1995.
69. Rainier S, Johnson L, Dobry C, et al: Relaxation of imprinted genes in human cancer. Nature 362:747-749, 1993.
70. Barlow D: Methylation and imprinting: From host defense to gene regulation? Science 260:309-310, 1993.
71. Pogribny I, Basnakian A, Miller B, et al. Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats. Cancer Res 55:1894-1901, 1995.
72. Antequera F, Macleod D, Bird A: Specific protection of methylated CpGs in mammalian nuclei. Cell 58:509-517, 1989.
73. Hansen R, Ellis N, Gartler S. Demethylation of specific sites in the 5′ region of the inactive X-linked human phosphoglycerate kinase gene correlates with the appearance of nuclease sensitivity and gene expression. Molec Cell Biol 8:4692-4699, 1988.
74. Leteurtre F, Kohlhage G, et al: Effects of DNA methylation on topoisomerase I and II cleavage activities. J Biol Chem 269:7893-7900, 1994.
75. Kim Y-I, Choi S, Mason JB: Folate deficiency induces DNA strand breaks within mutation-prone exons of the p53 gene in rat colon: Implications for colorectal carcinogenesis (abstract) Gastroenterology 110:A542, 1996.
76. Yunis J, Soreng A: Constitutive fragile sites and cancer. Science 226:1199-1204, 1984.
77. Green R, Phillips D, Chen A, et al: Effects of folate in culture medium on common fragile sites in lymphocyte chromosomes from normal and leukemic children. Hum Genet 81:9-12, 1988.
78. Everson R, Wehr C, Erexson G, et al: Association of marginal folate depletion with increased human chromosomal damage in vivo; demonstration by analysis of micronucleated erythrocytes. J Natl Cancer Inst 80:525-529, 1988.
79. Heath C: Cytogenetic observations in vitamin B12 and folate deficiency. Blood 27:800-815, 1966.
80. Das KC, Mohanty D, Garewal G: Cytogenetics in nutritional megaloblastic anaemia. Acta Haematol 76:146-154, 1986.
81. Branda R, Arthur D, Woods W, et al: Folate metabolism and chromosomal stability in the fragile X syndrome. Am J Med 77:602-611, 1984.
82. Choi S, Kim Y-I, Weitzel J, et al: Impaired DNA repair in the rat colon is a result of folate deficiency implications for colonic carcinogenesis. Gastroenterology A503: 1996.
83. Bryant P. Enzymatic restriction of mammalian cell DNA using Pvu II and BamH1: Evidence of the double strand break origin of chromosomal aberrations. Int J Radiat Biol 46:57-65, 1984.
84. Bryant P: Use of restriction enzymes to study relationships between DNA double strand breaks and other end-points in mammalian cells Int J Radiat Biol 54:869-890, 1988.
85. Branda R, Blickensderfer D: Folate deficiency increases genetic damage caused by alkylating agents and gamma irradiation in CHO cells. Cancer Res 53:5401-5408, 1993.
86. Borek C, Ong A, Morgan W, et al: Morphological transformation of 10T1/2 mouse embryo cells can be initiated by DNA double strand breaks alone. Mol Carcinog 4:243-247, 1991.
87. Bryant P, Riches A: Transformation of murine C3H 10T1/2 cells resulting from DNA double strand breaks induced by a restriction endonuclease Br J Cancer 60:852-854, 1989.
88. Zajac-Kaye M, Tso P: DNase I encapsulated in liposomes can induce neoplastic transformation of Syrian hamster embryo cells in culture. Cell 39:427-437, 1984.
89. Nelson W, Kastan M: DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Molec Cell Biol 14:1815-1823, 1994.
90. Sedwick W, Kutler M, Brown O: Antifolate-induced misincorporation of deoxyuridine monophosphate into DNA: Inhibition of high molecular weight DNA synthesis in human lymphoblastoid cells. Proc Natl Acad Sci USA 78:917-921, 1981.
91. Goulian M, Bleile B, Tseng B: Methotrexate-induced misincorporation of uracil into DNA Proc Natl Acad Sci USA 77:1956-1960, 1980.
92. Shen J-C, Rideout III W, Jones P: High frequency mutagenesis by a DNA methyltransferase. Cell 71:1073-1080, 1992.
93. Baker S, Preisinger A, Jessup J, et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumongenesis. Cancer Res 50:7717-7722, 1990.
94. Chandar N, Lombardi B: Liver cell proliferation and incidence of hepatocellular carcinomas in rats fed consecutively a choline-devoid and a choline-supplemented diet Carcinogenesis 9:259-263, 1988.
95. Reddy T, Ramanathan R, Shinozuka H, et al: Effects of dietary choline deficiency on the mutagenic activation of chemical carcinogens by rat liver. Cancer Lett 18:41-48, 1983.
96. da Costa K, Cochary E, Blusztajn J, et al: Accumulation of 1,2-sn-diacylglycerol with increased membrane-associated protein kinase C may be the mechanism for spontaneous hepatocarcinogenesis in choline deficient rats. J Biol Chem 268:2100-2105, 1993.
97. Rozengurt E: Earty signals in the mitogenic response. Science 234:161-166, 1986.
98. Kaibuchi K, Tsuda T, Kikuchi A, et al: Possible involvement of protein kinase C and calcium ion in growth factor-induced expression of c-myc oncogene in Swiss 3T3 fibroblasts. J Biol Chem 261:1187-1192, 1986.
99. Megidish T, Mazurek N: A mutant protein kinase C that can transform fibroblasts. Nature 342:807-811,1989
100. Baum C, Wali R, Sitrin M, et al: 1,2 dimethylhydrazine-induced alterations in protein kinase C activity in the rat preneoplastic colon Cancer Res 50:3915-3920, 1990.
101. +2-dependent protein kinase in human colon carcinomas. Cancer Res 47:2036-2039, 1987.
102. Sakanoue Y, Hatada T, Kusumoki M, et al: Protein kinase C activity as a marker for colorectal cancer. Int J Cancer 48:803-806, 1991.
103. Finkelstein J, Martin J: Methionine metabolism in mammals. J Biol Chern 259:9508-9513, 1984.
104. Dhur A, Galan P, Hercberg S: Folate status and the immune system. Prog Food Nutr Sci 15:43-60, 1991.
105. Williams E, Gross R, Newberne P: Effect of folate deficiency on the cell-mediated immune response in rats. Nutr Reports Intern 12:137-148, 1975.
106. Popescu N, Dipaolo J, Amsbaugh D: Integration sites of human papillomavirus-18 DNA sequences of HeLa cell chromosomes. Cytogenet Cell Genet 44:58-62, 1987.
107. Jacques P, Riggs K: B vitamins as risk factors for age-related diseases, in Rosenberg IH (ed): Proceedings of the 13th Annual Bristol Myers-Squibb Mead Johnson Nutrition Research Symposium: Nutritional Assessment of Elderly Population, New York, Raven Press, 1995.
108. Selhub J, Miller J: The pathogenesis of homocysteinemia. Am J Clin Nutr 55:131-13, 1992.
109. Paspatis G, Kalafatis E, Oros L, et al: Folate status and adenomatous colonic polyps. Dis Colon Rectum 38:64-68, 1995.